Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(20/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(20/week)
News
United States
(1285/week)
Manufacturing
(647/week)
Technology
(1298/week)
Energy
(498/week)
Other Manufacturing
(447/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Ascentage Pharma
May 23, 2024
ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug Candidates
Apr 24, 2024
ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST
Apr 07, 2024
AACR 2024 | Ascentage Pharma Presents Results from Three Studies at 2024 American Association of Cancer Research Annual Meeting
Mar 27, 2024
Ascentage Pharma Announces 2023 Annual Results
Mar 05, 2024
AACR 2024 | Ascentage Pharma to Present Three Preclinical Studies at 2024 American Association of Cancer Research Annual Meeting
Feb 13, 2024
Global Registrational Phase III Study of Olverembatinib (HQP1351) Cleared by FDA
Jan 16, 2024
Olverembatinib Included in Newest Guidelines on Chronic Myeloid Leukemia (CML) Management from the National Comprehensive Cancer Network (NCCN)
Jan 10, 2024
Ascentage Pharma Presented at 42nd Annual J.P. Morgan Healthcare Conference
Jan 01, 2024
Ascentage Pharma to Present at 42nd J.P. Morgan Healthcare Conference
Feb 02, 2021
Ascentage Pharma Released Preclinical Results of MDM2-p53 Inhibitor APG-115 in an Oral Presentation at WCLC 2020, Demonstrating Therapeutic Potential in STK11-Mutant Non-Small Cell Lung Cancer
Jan 13, 2021
Ascentage Pharma Presents Updates on its Global Clinical Development at the J.P. Morgan 39th Annual Healthcare Conference
Jan 04, 2021
Ascentage Pharma Announces its 9th Orphan Drug Designation from the US FDA in 2020, Setting a Record for Chinese Biopharmaceutical Companies
Dec 30, 2020
Ascentage Pharma Officially Included in Shenzhen-Hong Kong Stock Connect Program
Dec 11, 2020
PharmaBlock Enters Strategic Partnership with Ascentage Pharma
Dec 09, 2020
Ascentage Pharma Announces Updates on the Clinical Development of APG-2575, including an ORR of 70% in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
Dec 07, 2020
Ascentage Pharma Announces Positive Data from Pivotal Phase II Studies of HQP1351 (Olverembatinib) in Patients with TKI-Resistant Chronic Myeloid Leukemia (CML) at 2020 American Society of Hematology (ASH) Annual Meeting
Dec 03, 2020
Ascentage Pharma Appoints Mr. Gang Zhu as Chief Commercial Officer to Lead Commercial Initiatives
Dec 01, 2020
Ascentage Pharma Announces Clearances in China and the US for the Phase IIa Study of APG-115 Single Agent or in Combination with APG-2575 for the Treatment of Relapsed or Refractory T-cell Prolymphocytic Leukemia
Nov 29, 2020
Ascentage Pharma Enters into an Agreement with University of Michigan to obtain an exclusive license for a MDM2 Degrader using PROTAC Technology
Nov 24, 2020
Ascentage Pharma Announces First Patient Dosed in Europe in the Phase Ib/II Study of the Bcl-2 inhibitor APG-2575 in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Page 1
››
Latest News
May 25, 2024
Permian Resources Completes Liquidation of Lynden Energy Corp. by Making Application to Cease to be a...
May 25, 2024
Fonon at Cutting Edge of Additive Manufacturing in Mining
May 25, 2024
Danimer Scientific Receives Continued Listing Standard Notice from NYSE
May 25, 2024
Amerant Bank Donates 250 Tickets to Local Veterans and First Responders for Game 4 of Florida Panthers...
May 25, 2024
John Lawler to Highlight Progress of Ford+ Plan During ‘Chat’ at Deutsche Bank 2024 Global Automotive...
May 25, 2024
Bentley Systems, Incorporated Declares Second Quarter 2024 Dividend
May 25, 2024
ComEd Completes One of Nation’s First Neighborhood Scale Community Microgrids in Bronzeville on Chicago’s...
May 25, 2024
Brazil – UH-60M Black Hawk Helicopters
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events